ImmunoGen announced that Isabel Kalofonos has been appointed Senior Vice President and Chief Commercial Officer. Kalofonos joins ImmunoGen from Galderma, where she served as Senior Vice President and Global Head of the Prescription Business Unit.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IMGN:
- JPMorgan SMid cap biotech analyst to hold analyst/industry conference call
- Sutro transferred with Equal Weight from Overweight at Wells Fargo
- Immunogen confident in early Elahere launch, says Guggenheim
- ImmunoGen sees FY23 revenue $30M-$35M, consensus $117.67M
- ImmunoGen reports Q4 EPS (23c), consensus (30c)